MedPath
NMPA Approval

Moroxydine Hydrochloride Tablets

国药准字H51023915

September 30, 2020

国药准字H51023915

Drug Information

盐酸吗啉胍片

片剂

0.1g

化学药品

September 30, 2020

Company Information

Applicant Company

四川省成都市海峡两岸科技产业开发园

Manufacturing Company

四川省成都市海峡两岸科技产业开发园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸吗啉胍片 - NMPA 批准文号 | MedPath